Skip to main content
Erschienen in: Surgical Endoscopy 4/2019

Open Access 25.07.2018

A high preoperative Glasgow prognostic score predicts a high likelihood of conversion from laparoscopic to open surgery in patients with colon cancer

verfasst von: Yoshimi Iwasaki, Mitsuru Ishizuka, Kazutoshi Takagi, Hiroyuki Hachiya, Norisuke Shibuya, Yusuke Nishi, Taku Aoki, Keiichi Kubota

Erschienen in: Surgical Endoscopy | Ausgabe 4/2019

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Although the use of laparoscopic resection for colon cancer (LRC) has been increasing, conversion to open surgery sometimes becomes necessary because of intraoperative difficulties. Although the Glasgow prognostic score (GPS) is well known to be a predictor of outcome in patients with various cancers, it is unclear whether the preoperative GPS can predict the need for conversion from laparoscopic to open surgery.

Objective

To investigate factors predictive of conversion from laparoscopic to open surgery in patients with colon cancer.

Methods

Data from 308 consecutive patients who underwent LRC between January 2006 and March 2017 were retrospectively enrolled. Preoperative clinical factors in patients who had undergone LRC were compared between conversion and non-conversion groups, and multivariate regression analysis was performed to identify preoperative factors that might predict conversion from laparoscopic to open surgery.

Results

Among 308 patients who had undergone LRC, conversion to open surgery was necessary in 28 (9.1%). Sixteen of the latter patients (6.8%) had GPS 0 (among a total of 234) and 6 (11.5%) had GPS 1 (among a total of 52). The proportion of patients with GPS 2 who required conversion was 27.2% (6/22), which was significantly higher than for those with GPS 0 or 1. Multivariate analysis demonstrated that GPS 2 (odds ratio [OR] 3.352; 95% confidence interval [CI] 1.049–10.71; p = 0.041) and preoperative ileus (OR 7.405; 95% CI 2.386–22.98; p = 0.001) were independent factors predictive of conversion from laparoscopic to open surgery.

Conclusions

A high preoperative GPS is an independent factor predictive of conversion from laparoscopic to open surgery in patients with colon cancer.
Abkürzungen
ASA
American Society of Anesthesiologists
BMI
Body mass index
CA19-9
Carbohydrate antigen 19-9
CEA
Carcinoembryonic antigen
CRP
C-reactive protein
CT
Computed tomography
GPS
Glasgow prognostic score
Hgb
Hemoglobin
LRC
Laparoscopic resection for colon cancer
TNM
Tumor-node-metastasis
TPN
Total parenteral nutrition
The use of laparoscopic surgery has become widespread because of its minimal invasiveness. Randomized controlled trials have revealed that the initial and long-term outcomes of laparoscopic resection for colon cancer (LRC) are not inferior to those of conventional open surgery [14]. On the basis of this evidence, LRC has been widely adopted, even for patients with advanced colon cancer. However, recent studies have demonstrated that patients who undergo conversion from laparoscopic to open surgery have poorer initial and long-term outcomes than those who undergo conventional surgery [3, 5, 15]. The proportion of patients undergoing elective LRC requiring conversion from laparoscopic to open surgery is reported to be 10–23% [6, 7]. In order to reduce this conversion rate, adequate patient selection is required.
The Glasgow prognostic score (GPS) is an inflammation-based prognostic system involving only serum C-reactive protein (CRP) and albumin, and widely considered to be one of the most useful scoring systems for prognostication of patients with various cancers [810]. However, no previous studies have investigated the relationship between the GPS and conversion from laparoscopic to open surgery.
Here, we hypothesized that patients with a high GPS might have not only a poorer prognosis but also a higher likelihood of requiring conversion from laparoscopic to open surgery than those with a low GPS. To verify this hypothesis, we conducted a retrospective cohort study to investigate whether the preoperative GPS in patients with colon cancer is predictive of conversion from laparoscopic to open surgery.

Patients and methods

For this study, we enrolled 308 patients who had undergone LRC at Dokkyo Medical University Hospital between January 2006 and March 2017. None of them had undergone laparoscopic surgery for rectal cancer or benign diseases. Patients who had undergone LRC combined with hepatectomy for hepatic metastasis were excluded. The 308 patients with colon cancer were reviewed retrospectively, and preoperative and intraoperative data for the same period were collected.
We considered that LRC was indicated for patients with colon cancer that had been diagnosed clinically as T1–T4a/N0-2/M0-1 on the basis of preoperative colonoscopy and abdominal computed tomography (CT). If preoperative ileus had been sufficiently improved by decompression, LRC was approved for such patients by preoperative conference. Even when LRC had been approved, the final decision was confirmed after the patients had furnished informed consent.
For univariate analysis using logistic regression, patients were divided into two age groups (≥ 65/< 65) on the basis of the definition of “elderly” by the World Health Organization [11]. Body mass index (BMI) was divided into two categories (≥ 25/< 25) on the basis of the definition of obesity [12]. Preoperative ileus was diagnosed when abdominal CT demonstrated colon or small bowel distension accompanied by symptoms such as nausea, vomiting, and abdominal pain.
Laboratory parameters including hemoglobin (Hgb) (upper physiological value, 12 g/dL), CRP (upper physiological value, 0.14 mg/dL), albumin (upper physiological value, 4.1 g/dL), and tumor markers such as carcinoembryonic antigen (CEA) (upper physiological value, 5.0 ng/mL) and carbohydrate antigen 19-9 (CA19-9) (upper physiological value, 37 U/mL) were measured on the initial day to exclude signs of clinical improvement resulting from treatments such as blood transfusion or total parenteral nutrition (TPN).
The GPS was estimated as described previously [8, 9]. Patients with both an elevated CRP level (> 1.0 mg/dL) and hypoalbuminemia (< 3.5 g/dL) were allocated a score of 2. Patients with only one of these biochemical abnormalities were allocated a score of 1, and patients with neither were allocated a score of 0. Therefore, the cut-off values of CRP and albumin were determined on the basis of this definition.
Tumor location was determined by preoperative colonoscopy or barium enema and reconfirmed using intraoperative observation. The cecum, ascending colon, and transverse colon were defined as the right-sided colon, whereas the descending colon, sigmoid colon, and rectosigmoid colon were defined as the left-sided colon.
Conversion to open surgery was defined as follows: (1) An incision longer than 8 cm was required. Very large tumors that required an incision exceeding 8 cm were excluded on the basis of this criterion. (2) Open techniques were used. The decision to convert from laparoscopic to open surgery was finally made at the discretion of the surgeons. Therefore, tumor size was also divided into two categories (> 7/≤ 7 cm) for univariate analysis.
Data were expressed as the median with range. Differences between the two groups divided by the need for conversion (±) or the GPS (0–1/2) were analyzed using the Mann–Whitney U test or Chi-Squared test. Univariate and multivariate analyses were performed using logistic regression. Statistical analyses were performed using the SPSS statistical software package (version 23.0, IBM Co., New York, NY, USA) at a significance level of P < 0.05.

Results

This study included 172 males and 136 females with a median age of 68 years (range 31–100 years); 234 had GPS 0, 52 had GPS 1, and 22 had GPS 2. Seventeen patients had preoperative ileus. Among them, 7 patients underwent preoperative decompression using long tube insertion (n = 5) and colonic stenting (n = 2). The other 10 received TPN instead of oral intake. Conversion from laparoscopic to open surgery was needed for 28 patients (9.1%). The conversion rate in patients with GPS 2 was 27.3%, and that for patients with GPS 0 and 1 was 6.8 and 11.5%, respectively. The conversion rate for patients with GPS 2 was significantly higher than that for patients with GPS 0 or 1. There were no significant differences between the two groups (conversion +/conversion −) in terms of age, gender, BMI, American Society of Anesthesiologists (ASA), presence of cardiopulmonary disease, previous laparotomy, preoperative Hgb and CEA levels, tumor location and size, and pathological tumor-node-metastasis (pTNM) stage and pathology. Preoperative ileus and very large tumors were observed more frequently in patients who required conversion than in those who did not (Table 1). The conversion rate in patients with preoperative ileus was 41.2% (7/17) and that in patients with very large tumors (> 7 cm) and with stages III and IV was 20.7% (6/29) and 14.4% (17/118), respectively.
Table 1
Characteristics of patients who underwent laparoscopic resection for colon cancer with or without conversion
Variables
Conversion (+)
(n = 28)
Conversion (−)
(n = 280)
P
Age (years)
69 (41–89)
67 (31–100)
0.537
Gender
   
 Male
17 (60.7)
155 (55.4)
 
 Female
11 (39.3)
125 (44.6)
0.586
BMI (kg/m2)
22.8 (16.3–32.6)
22.2 (13.3–37.6)
0.766
ASA grade
   
 1
6 (21.4)
55 (19.6)
 
 2
20 (71.5)
205 (73.2)
 
 3
2 (7.1)
20 (7.2)
0.974
Cardiopulmonary disease
   
 Absence
23 (82.1)
228 (81.4)
 
 Presence
5 (17.9)
52 (18.6)
0.926
Previous laparotomy
   
 Absence
18 (64.2)
196 (69.8)
 
 Presence
10 (35.7)
84 (30.2)
0.531
Preoperative ileus
   
 Absence
21 (75.0)
270 (96.4)
 
 Presence
7 (25.0)
10 (3.6)
< 0.001
CEA (ng/l)
3.7 (1–1450)
2.9 (1–3330)
0.439
CA19-9 (U/mL)
6 (2-396)
8 (2–12000)
0.648
Hgb (g/dL)
12.6 (7.6–16.9)
12.7 (4.9–17.1)
0.726
GPS
   
 0
16 (57.2)
218 (77.9)
 
 1
6 (21.4)
46 (16.4)
 
 2
6 (21.4)
16 (5.7)
0.005
Tumor location
   
 Right-sided colon
12 (42.9)
126 (45.0)
 
 Left-sided colon
16 (57.1)
154 (55.0)
0.828
Tumor size (mm)
38 (2–80)
37 (5–120)
0.418
Very large tumor (> 7 cm)
   
 Absence
22 (78.6)
257 (91.8)
 
 Presence
6 (21.4)
23 (8.2)
0.022
pTNM stage
   
 0
2 (7.1)
18 (6.4)
 
 I
5 (17.9)
83 (29.6)
 
 II
4 (14.3)
78 (27.9)
 
 III
13 (46.4)
80 (28.6)
 
 IV
4 (14.3)
21 (7.5)
0.128
Pathology
   
 Well
13 (46.4)
103 (36.8)
 
 Moderately
12 (42.9)
164 (58.5)
 
 Poorly
2 (7.1)
5 (1.8)
 
 Mucinous
1 (3.6)
8 (2.9)
0.173
Categorical variables were expressed as number (percent) and compared using Chi-Square test. Continuous variables were expressed as median (range) and compared using Mann–Whitney test
ASA American Society of Anesthesiologists, BMI body mass index, CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, GPS Glasgow prognostic score, pTNM pathologic tumor, nodes, metastases
Patients with GPS 2 had a significantly lower BMI than those with GPS 0 or 1. The preoperative serum level of CEA was significantly higher in patients with GPS 2 than in those with GPS 0 or 1. However, there was no significant difference between the two groups (GPS 0 or 1/GPS 2) in the preoperative serum level of CA19-9. The preoperative Hgb level was significantly lower in patients with GPS 2 than in those with GPS 0 or 1. Although there were no significant differences between the two groups in tumor location and pathology, tumor size and pTNM stage were more advanced in patients with GPS 2 than in those with GPS 0 or 1. The median size of the tumor in patients with GPS 0 or 1, and those with GPS 2, was 3.5 and 5.1 cm, respectively (Table 2).
Table 2
Relationships between clinical characteristics and GPS
Variables
GPS 0 or 1
(n = 286)
GPS2
(n = 22)
P
Age (years)
67 (31–100)
74 (48–87)
0.065
Gender
   
 Male
161 (56.3)
11 (50.0)
 
 Female
125 (43.7)
11 (50.0)
0.567
BMI (kg/m2)
22.4 (13.3–37.6)
20.6 (15.9–30.7)
0.011
ASA grade
   
 1
59 (20.6)
2 (9.1)
 
 2
209 (73.1)
16 (72.7)
 
 3
18 (6.3)
4 (18.2)
0.067
Cardiopulmonary disease
   
 Absence
236 (82.5)
15 (68.2)
 
 Presence
50 (17.5)
7 (31.8)
0.095
Previous laparotomy
   
 Absence
199 (69.6)
15 (68.2)
 
 Presence
87 (30.4)
7 (31.8)
0.891
Preoperative ileus
   
 Absence
271 (94.8)
20 (90.9)
 
 Presence
15 (5.2)
2 (9.1)
0.447
CEA (ng/l)
2.9 (1.0–294)
6.2 (1.3–3330)
0.007
CA19-9 (U/mL)
7 (2–12000)
9 (2–1410)
0.234
Hgb (g/dL)
12.9 (4.9–17.1)
11.3 (7.4–13.8)
< 0.001
Tumor location
   
 Right-sided colon
126 (44.1)
12 (54.5)
 
 Left-sided colon
160 (55.9)
10 (45.5)
0.34
Tumor size (mm)
35 (2–120)
51 (22–105)
0.001
Very large tumor (> 7 cm)
 Absence
265 (92.7)
14 (63.6)
< 0.001
 Presence
21 (7.3)
8 (36.4)
pTNM stage
   
 0
19 (6.6)
1 (4.5)
< 0.001
 I
87 (30.4)
1 (4.5)
 II
74 (25.9)
8 (36.4)
 III
88 (30.8)
5 (22.8)
 IV
18 (6.3)
7 (31.8)
Pathology
   
 Well
109 (38.1)
7 (31.9)
0.805
 Moderately
163 (57.0)
13 (59.1)
 Poorly
6 (2.1)
1 (4.5)
 Mucinous
8 (2.8)
1 (4.5)
Categorical variables were expressed as number (percent) and compared using Chi-Square test. Continuous variables were expressed as median (range) and compared using Mann–Whitney test
ASA American Society of Anesthesiologists, BMI body mass index, CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, GPS Glasgow prognostic score, pTNM pathologic tumor, nodes, metastases
Univariate analyses revealed that preoperative ileus (presence/absence), GPS (2/0,1), very large tumor (> 7/≤ 7 cm), and pTNM stage (III, IV/0, I, II) were associated with conversion from laparoscopic to open surgery (Table 3). Multivariate analysis using these four selected factors demonstrated that the presence of preoperative ileus and GPS 2 were independent factors predictive of conversion from laparoscopic to open surgery (Table 3).
Table 3
Univariate and multivariate analyses in relation to conversion to open surgery
Variables
Univariate analyses
Multivariate analysis
P value
Odds ratio
95% CI
P value
Odds ratio
95% CI
Age (≥  65/< 65)
0.467
1.350
0.601–3.030
   
Gender (female/male)
0.587
0.802
0.363–1.775
   
BMI (> 25/≤ 25)
0.254
1.632
0.703–3.784
   
ASA (III/I, II)
1.000
1.000
0.221–4.520
   
Cardiopulmonary disease (presence/absence)
0.926
0.953
0.346–2.625
   
Previous laparotomy (presence/absence)
0.532
1.296
0.574–2.926
   
Preoperative ileus (presence/absence)
< 0.001
9.000
3.109–26.06
0.001
7.405
2.386–22.98
CEA (> 5.0/≤ 5.0 ng/mL)
0.480
1.341
0.594–3.030
   
CA19-9 (> 37/≤ 37 U/mL)
0.855
1.124
0.318–3.970
   
Hgb (< 10/≥ 10 g/dL)
0.689
1.232
0.444–3.420
   
GPS (2/0, 1)
0.004
4.500
1.600–12.66
0.041
3.352
1.049–10.71
Very large tumor (> 7/≤ 7 cm)
0.029
3.047
1.123–8.271
0.193
2.144
0.680–6.766
Tumor location (left/right)
0.828
1.091
0.498–2.391
   
pTNM stage (III, IV/0, I, II)
0.013
2.739
1.235–6.075
0.132
1.929
0.821–4.536
Pathology (poorly, mucinous/well, moderately)
0.181
2.465
0.658–9.232
   
Bold values indicate significance at P < 0.05
ASA American Society of Anesthesiologists, BMI body mass index, CA19-9 carbohydrate antigen 19-9, CI confidence interval, CEA carcinoembryonic antigen, GPS Glasgow prognostic score, pTNM pathologic tumor, nodes, metastases
The reasons for conversion to open surgery are listed in Table 4. Major reasons for conversion were severe intra-abdominal adhesion (n = 9) and a narrow operative space (n = 9). Direct invasion to adjacent organs was an additional reason (n = 7), and pathological examination revealed that such direct invasion was diagnosed in only three patients. Other reasons for conversion were uncontrollable intraoperative bleeding (n = 2) and hypotension (n = 1). The conversion rate in patients with preoperative ileus was 41.2%. Two patients had both GPS 2 and preoperative ileus, and both underwent conversion to open surgery (data not shown).
Table 4
Reasons for conversion to open surgery
Reason
Number (%)
Adhesion
9 (32)
Narrow operative space
9 (32)
Direct invasion to adjacent organ
7 (25)
Bleeding
2 (7)
Intra-operative hypotension
1 (4)
Total
28 (100)

Discussion

The GPS is a well-known inflammation-based prognostic system used in patients with various cancers. Forrest et al. first reported the prognostic use of the GPS in patients with non-small-cell lung cancer in 2004 [8, 9]. In 2007, McMillan et al. and Ishizuka et al. subsequently reported that a high preoperative GPS was able to predict poor outcome after resection of colorectal cancer [13, 14]. However, the relationship between the GPS and conversion from laparoscopic to open surgery has never been investigated. To our knowledge, this is the first retrospective study to have investigated the relationship between the preoperative GPS and conversion from laparoscopic to open surgery in patients with colon cancer. Our findings revealed that a high preoperative GPS was associated with conversion from laparoscopic to open surgery.
Although preoperative ileus, preoperative GPS 2, tumor size (> 7 cm), and stage (III, IV) were factors predictive of conversion from laparoscopic to open surgery, BMI, male gender, ASA, and previous laparotomy were not related to conversion from laparoscopic to open surgery in this study.
A meta-analysis of laparoscopic colorectal cancer surgery has concluded that laparoscopic resection was less likely to be completed in males and in patients with a high BMI [15]. It is well known that male gender, presence of rectal cancer, and a high BMI are factors predictive of conversion from laparoscopic to open surgery due to the narrow pelvic space and technical difficulties [16]. These factors were not considered in the present study because no rectal cancer patients were included and most patients had a lower BMI than those reported in western countries [17].
The same meta-analysis reported that laparoscopic resection was less likely to be completed in patients with locally advanced tumors and rectal tumors [15]. As a matter of course, locally advanced tumors such as those at stage III and IV, and also very large tumors, would have had a higher likelihood of necessitating conversion from laparoscopic to open surgery in the present series. However, tumors at stages III and IV, and those that were very large, were not significantly associated with such conversion. Multivariate regression analysis demonstrated that preoperative ileus and GPS 2 were independent risk factors for conversion to open surgery, rather than stage III and IV and very large tumors. This study is the only one so far to have considered not only gender, age, BMI, ASA, previous laparotomy, and cardiopulmonary disease, but also preoperative ileus and GPS; most previous studies that investigated conversion to open surgery in LRC did not consider these preoperative factors, including GPS [1, 2, 17, 18].
Although patients with preoperative GPS 2 had a lower BMI than those with GPS 0 or 1, the former showed a higher rate of conversion than those with GPS 0 or 1. A high GPS was defined as the presence of hypoalbuminemia and an increased serum level of CRP. It is well known that the serum levels of albumin and CRP are related to inflammation due to the influence of inflammatory cytokines such as IL-6 [19]. In addition, cancer progression is closely associated with inflammation induced by abundant pro-inflammatory cytokines [20]. Therefore, a high GPS may reflect not only cancer progression but also the systemic inflammatory response, rather than conventional tumor-related factors such as stage and a very large tumor size.
It has been reported that preoperative hypoalbuminemia was the most important factor predictive of conversion to open surgery in patients undergoing laparoscopic cholecystectomy for cholecystolithiasis [21]. A high GPS, which includes hypoalbuminemia, would be a very feasible indicator to predict conversion in laparoscopic surgery patients with malignant disease, because hypoalbuminemia would also be strongly associated with conversion in benign disease.
Preoperative ileus was a factor strongly predictive of conversion to open surgery in the present study. In fact, approximately 15–22% of patients with colorectal cancer have symptoms of acute obstruction [22, 23]. Most patients with bowel obstruction undergo open surgery or emergency surgery instead of laparoscopic surgery, because bowel obstruction is one of the most common reasons for conversion to open surgery [24].
Recent studies have revealed that colonic stenting, as a bridge to elective surgery, can contribute to not only an increased rate of laparoscopic surgery but also to a decreased conversion rate [25, 26]. Although most of the present patients with preoperative ileus were managed by TPN instead of oral intake, intraoperative bowel distension was not fully improved. Therefore, laparoscopic surgery in such patients would be more difficult than for those without preoperative ileus, and the rate of conversion to open surgery might be increased in such patients. Surprisingly, in the present study, the conversion rate was 100% in patients who had both preoperative ileus and GPS 2.
In conclusion, this retrospective study has demonstrated that the GPS is applicable for routine preoperative clinical assessment of patients with colon cancer and is useful for decision-making. Because a high preoperative GPS is associated with a high rate of conversion to open surgery, the GPS would be a feasible and valuable tool for surgical decision-making in colon cancer patients undergoing LRC.

Compliance with ethical standards

Disclosures

Yoshimi Iwasaki, Mitsuru Ishizuka, Kazutoshi Takagi, Hiroyuki Hachiya, Norisuke Shibuya, Yusuke Nishi, Taku Aoki and Keiichi Kubota have no conflicts of interest or financial ties to disclose.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Fleshman J, Sargent DJ, Green E, Anvari M, Stryker SJ, Beart RW Jr et al (2007) Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST study group trial. Ann Surg 246:655–664CrossRef Fleshman J, Sargent DJ, Green E, Anvari M, Stryker SJ, Beart RW Jr et al (2007) Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST study group trial. Ann Surg 246:655–664CrossRef
2.
Zurück zum Zitat The colon cancer laparoscopic or open resection study group (2009) Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 10:44–52CrossRefPubMed The colon cancer laparoscopic or open resection study group (2009) Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 10:44–52CrossRefPubMed
3.
Zurück zum Zitat Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG et al (2013) Long-term follow-up of the medical research council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg 100:75–82CrossRef Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG et al (2013) Long-term follow-up of the medical research council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg 100:75–82CrossRef
4.
Zurück zum Zitat Kitano S, Inomata M, Mizusawa J, Katayama H, Watanabe M, Yamamoto S et al (2017) Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol 2:261–268CrossRef Kitano S, Inomata M, Mizusawa J, Katayama H, Watanabe M, Yamamoto S et al (2017) Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol 2:261–268CrossRef
5.
Zurück zum Zitat Moghadamyeghaneh Z, Masoomi H, Mills SD, Carmichael JC, Pigazzi A, Nguyen NT et al (2014) Outcomes of conversion of laparoscopic colorectal surgery to open surgery. JSLS 18:230CrossRef Moghadamyeghaneh Z, Masoomi H, Mills SD, Carmichael JC, Pigazzi A, Nguyen NT et al (2014) Outcomes of conversion of laparoscopic colorectal surgery to open surgery. JSLS 18:230CrossRef
6.
Zurück zum Zitat Tekkis PP, Senagore AJ, Delaney CP (2005) Conversion rates in laparoscopic colorectal surgery: a predictive model with, 1253 patients. Surg Endosc 19:47–54CrossRefPubMed Tekkis PP, Senagore AJ, Delaney CP (2005) Conversion rates in laparoscopic colorectal surgery: a predictive model with, 1253 patients. Surg Endosc 19:47–54CrossRefPubMed
7.
Zurück zum Zitat Gonzalez R, Smith CD, Mason E, Duncan T, Wilson R, Miller J et al (2006) Consequences of conversion in laparoscopic colorectal surgery. Dis Colon Rectum 49:197–204CrossRefPubMed Gonzalez R, Smith CD, Mason E, Duncan T, Wilson R, Miller J et al (2006) Consequences of conversion in laparoscopic colorectal surgery. Dis Colon Rectum 49:197–204CrossRefPubMed
8.
Zurück zum Zitat Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2004) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90:1704–1706CrossRefPubMedPubMedCentral Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ (2004) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90:1704–1706CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dagg K, Scott HR (2005) A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 92:1834–1836CrossRefPubMedPubMedCentral Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dagg K, Scott HR (2005) A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 92:1834–1836CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Iwasaki Y, Ishizuka M, Kato M, Kita J, Shimoda M, Kubota K (2013) Usefulness of an inflammation-based prognostic score (mGPS) for predicting survival in patients with unresectable malignant biliary obstruction. World J Surg 37:2222–2228CrossRefPubMed Iwasaki Y, Ishizuka M, Kato M, Kita J, Shimoda M, Kubota K (2013) Usefulness of an inflammation-based prognostic score (mGPS) for predicting survival in patients with unresectable malignant biliary obstruction. World J Surg 37:2222–2228CrossRefPubMed
11.
Zurück zum Zitat World Health Organization (2018) WHO global report on falls prevention in old age 2007. World Health Organization World Health Organization (2018) WHO global report on falls prevention in old age 2007. World Health Organization
12.
Zurück zum Zitat World Health Organization (2018) WHO global health observatory data: overweight and obesity World Health Organization (2018) WHO global health observatory data: overweight and obesity
13.
Zurück zum Zitat McMillan DC, Crozier JE, Canna K, Angelson WJ, McArdle CS (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22:881–886CrossRefPubMed McMillan DC, Crozier JE, Canna K, Angelson WJ, McArdle CS (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22:881–886CrossRefPubMed
14.
Zurück zum Zitat Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246:1047–1051CrossRef Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246:1047–1051CrossRef
15.
Zurück zum Zitat Clancy C, O’Leary DPO, Burke JP, Redmond HP, Coffey JC, Kerin MJ et al (2014) A meta-analysis to determine the oncological implications of conversion in laparoscopic colorectal cancer surgery. Colorectal Dis 17:482–490CrossRef Clancy C, O’Leary DPO, Burke JP, Redmond HP, Coffey JC, Kerin MJ et al (2014) A meta-analysis to determine the oncological implications of conversion in laparoscopic colorectal cancer surgery. Colorectal Dis 17:482–490CrossRef
16.
Zurück zum Zitat Thorpe H, Jayne DG, Guillou PJ, Quirk P, Copeland J, Brown JM et al (2008) Patient factors influencing conversion from laparoscopically assisted to open surgery for colorectal cancer. Br J Surg 95:199–205CrossRefPubMed Thorpe H, Jayne DG, Guillou PJ, Quirk P, Copeland J, Brown JM et al (2008) Patient factors influencing conversion from laparoscopically assisted to open surgery for colorectal cancer. Br J Surg 95:199–205CrossRefPubMed
17.
Zurück zum Zitat Yamamoto S, Inomata M, Katayama H, Mizusawa J, Etoh T, Konishi F et al (2014) Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG0404. Ann Surg 260:23–30CrossRefPubMed Yamamoto S, Inomata M, Katayama H, Mizusawa J, Etoh T, Konishi F et al (2014) Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG0404. Ann Surg 260:23–30CrossRefPubMed
18.
Zurück zum Zitat Bilimoria KY, Bentrem DJ, Merkow RP, Nelson H, Wang E, Ko CY et al (2008) Laparoscopic-assisted vs. open colectomy for cancer: comparison of short-term outcomes from 121 Hospitals. J Gastrointest Surg 12:2001–2009CrossRefPubMed Bilimoria KY, Bentrem DJ, Merkow RP, Nelson H, Wang E, Ko CY et al (2008) Laparoscopic-assisted vs. open colectomy for cancer: comparison of short-term outcomes from 121 Hospitals. J Gastrointest Surg 12:2001–2009CrossRefPubMed
19.
Zurück zum Zitat Ramadori G, Van Damme J, Rieder H (1988) Meyer zum Büschenfelde KH. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur J Immunol 18:1259–1264CrossRefPubMed Ramadori G, Van Damme J, Rieder H (1988) Meyer zum Büschenfelde KH. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur J Immunol 18:1259–1264CrossRefPubMed
21.
Zurück zum Zitat Ishizuka M, Shibuya N, Shimoda M, Kato M, Aoki T, Kubota K (2016) Preoperative hypoalbuminemia is an independent risk factor for conversion from laparoscopic to open cholecystectomy in patients with cholecystolithiasis. Asian J Endosc Surg 9:275–280CrossRefPubMed Ishizuka M, Shibuya N, Shimoda M, Kato M, Aoki T, Kubota K (2016) Preoperative hypoalbuminemia is an independent risk factor for conversion from laparoscopic to open cholecystectomy in patients with cholecystolithiasis. Asian J Endosc Surg 9:275–280CrossRefPubMed
22.
Zurück zum Zitat Ohman U (1982) Prognosis in patients with obstructing colorectal carcinoma. Am J Surg 143:742–747CrossRefPubMed Ohman U (1982) Prognosis in patients with obstructing colorectal carcinoma. Am J Surg 143:742–747CrossRefPubMed
23.
Zurück zum Zitat McArdle CS, McMillan DC, Hole DJ (2006) The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer. Br J Surg 93:483–488CrossRef McArdle CS, McMillan DC, Hole DJ (2006) The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer. Br J Surg 93:483–488CrossRef
24.
Zurück zum Zitat Yang C, Wexner SD, Safar B, Jobanputra S, Jin H, Li VK et al (2009) Conversion in laparoscopic surgery: does intraoperative complication influence outcome? Surg Endosc 23:2454–2458CrossRefPubMed Yang C, Wexner SD, Safar B, Jobanputra S, Jin H, Li VK et al (2009) Conversion in laparoscopic surgery: does intraoperative complication influence outcome? Surg Endosc 23:2454–2458CrossRefPubMed
25.
Zurück zum Zitat Park SJ, Lee KY, Kwon SH, Lee SH (2016) Stenting as a bridge to surgery for obstructive colon cancer: does it have surgical merit or oncologic demerit? Ann Surg Oncol 23:842–848CrossRefPubMed Park SJ, Lee KY, Kwon SH, Lee SH (2016) Stenting as a bridge to surgery for obstructive colon cancer: does it have surgical merit or oncologic demerit? Ann Surg Oncol 23:842–848CrossRefPubMed
26.
Zurück zum Zitat Ji WB, Kwak JM, Kang DW, Kwak HD, Um JW, Lee SI et al (2017) Clinical benefits and oncologic equivalence of self-expandable metallic stent insertion for right-sided malignant colonic obstruction. Surg Endosc 31:153–158CrossRefPubMed Ji WB, Kwak JM, Kang DW, Kwak HD, Um JW, Lee SI et al (2017) Clinical benefits and oncologic equivalence of self-expandable metallic stent insertion for right-sided malignant colonic obstruction. Surg Endosc 31:153–158CrossRefPubMed
Metadaten
Titel
A high preoperative Glasgow prognostic score predicts a high likelihood of conversion from laparoscopic to open surgery in patients with colon cancer
verfasst von
Yoshimi Iwasaki
Mitsuru Ishizuka
Kazutoshi Takagi
Hiroyuki Hachiya
Norisuke Shibuya
Yusuke Nishi
Taku Aoki
Keiichi Kubota
Publikationsdatum
25.07.2018
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 4/2019
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-018-6369-8

Weitere Artikel der Ausgabe 4/2019

Surgical Endoscopy 4/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.